The non invasive neurostimulation devices market is estimated to be worth $1 billion in 2020 and is expected to grow at CAGR of 11% during the forecast period. Over the past few decades, the prevalence of neurological disorders has been increasing at an alarming rate, particularly among the geriatric population across the world. In fact, nearly 1 million Americans are reported to be living with Parkinson

This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the product

The AI in medical imaging market size is projected to grow from $1.75 billion in 2024 to $8.56 billion by 2030, growing at a CAGR of 30% during the forecast period from 2024 to 2030. Notably, in situations characterized by low physician / pathologist to patient ratios, the conventional mode of operation is rendered inadequate. Experts have predicted a shortage of 10,000 to 40,000 physicians, by 2030, in the US alone. Over time, various industry stakeholders have designed proprietary deep learnin...

The global diabetes drug delivery devices market, valued at USD 17 billion in 2025, is projected to reach USD 18 billion in 2026 and USD 31 billion by 2030, with a 14.1% CAGR during the forecast period 2026 to 2030. It is worth mentioning that according to the WHO, more than 400 million individuals across the world are currently suffering from diabetes; this number is estimated to reach over 570 million by 2030. Further, in patients with diabetes, glycemic control is required multiple times i...

This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the product

The drug repurposing market is estimated to be worth $313 million in 2020 and is expected to grow at CAGR of 14.7% during the forecast period. Of late, the repurposing of marketed / shelved / pipeline candidates for the treatment of diseases different from what they were originally developed for, has emerged as a viable business strategy. In fact, of 28 drugs (including both novel and repurposed) approved by the USFDA in the first quarter of 2020, 12 were repurposed drugs. Further, it is estimat...

This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the product

This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the product

This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment about the drug

One of the key objectives of the report was to estimate the existing market size and the future opportunity of therapies for Pemphigus vulgaris, over the next decade. Based on multiple parameters, such as disease prevalence, anticipated adoption of the forecasted therapies and the likely selling price of such therapeutic products, we have provided informed estimates on the evolution of the market for the period 2020-2030. It features an in-depth analysis, highlighting the current treatment pract...

This report provides an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment of Neuromyelitis optica. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the drug

This report provides an informed opinion on the likely adoption of therapeutics designed to treat peanut allergy. It features an in-depth analysis, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape and its growth prospects over the coming years, providing information about the product

This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the product

This report provides an informed opinion on the likely adoption of therapeutics designed to treat multi-drug resistant tuberculosis. It features an in-depth analysis, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the product

This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the product

The global proteome profiling market, valued at USD 8 billion in 2025, is projected to reach USD 10 billion in 2026 and USD 16 billion by 2030, with a 12.2% CAGR during the forecast period 2026 to 2030. Proteome profiling refers to the large-scale, high-throughput analysis of biological samples for the detection, identification, and functional characterization of resident proteins. Currently, the demand for proteome profiling is high, given the growing pipeline of peptide synthesis. In fact, si...

The high energy / hazardous chemistry market is estimated to be worth $14 billion in 2020 and is expected to grow at CAGR of 8% during the forecast period. In pharmaceutical contract manufacturing, the use of certain hazardous chemical reactions has been shown to enable developers to optimize existing production processes, as well as improve yields. As a result, the number of process steps are essentially reduced, when compared to using conventional synthesis chemistries. However, they are usua...

The healthcare digital marketing market is estimated to be worth $305 million in 2020 and is expected to grow at CAGR of 26% during the forecast period. Advent of smartphones coupled to the easy accessibility of information on the internet, has rendered it crucial for companies to establish a digital presence. In fact, a recent study stated that digital advertising is expected to account for around 50% of the overall global advertisement spend by 2021. Further, it is encouraging to note that ove...

The vector purification market is estimated to be worth $155 million in 2020 and is expected to grow at compounded annual growth rate (CAGR) of 21% during the forecast period. Since the approval and launch of cell and gene therapy products, such as Zolgensma

The endocannabinoid system market is estimated to be worth $5.4 billion in 2030, growing at a CAGR of 28% during the forecast period. It is worth mentioning that chronic conditions, such as arthritis, cancer, diabetes, and heart disease are known to affect approximately 133 million Americans, representing over 40% of the total US population. This number is projected to grow to 157 million by the end of 2020. Notably, drugs that offer symptomatic relief are the only treatment option currently ava...